Tuesday, February 24, 2026 Today, Abcuro released topline results from their Phase 2/3 MUSCLE study evaluating ulviprubart in patients with inclusion body myositis (IBM). Briefly, the study did not demonstrate…
Continue Reading
Be the reason a patient can attend MyoCon Give Today
Tuesday, February 24, 2026 Today, Abcuro released topline results from their Phase 2/3 MUSCLE study evaluating ulviprubart in patients with inclusion body myositis (IBM). Briefly, the study did not demonstrate…
Continue Reading
Melissa Wilder’s journey with dermatomyositis has been long, winding, and marked by extraordinary resilience. Before myositis entered her life, she was someone who embraced possibility—so much so that she once…
Continue Reading
The myositis community mourns the loss of James “Jim” Mathews of Grand Haven, Michigan, who passed away on February 5, 2026, surrounded by his loving wife, Cathy, and six children….
Continue Reading
If you have a form of myositis and take steroids as part of your treatment, you already know how challenging this can be. Corticosteroids like prednisone are often the first…
Continue Reading
For most of her life, Malarie Hensley defined herself by motion. A dedicated runner, she completed two marathons and eight half‑marathons, spending countless weekends on long runs with friends. When…
Continue Reading